Log in using OpenID

Acute Pain Market Size, Causes, Share, Trends and Pipeline Review, H1 2016

Global Markets Direct's, 'Acute Pain - Pipeline Review, H1 2016', provides an overview of the Acute Pain pipeline landscape. Read More @
Acute Pain Market Size, Share, Trends, Growth, Pipeline
Review, H1 2016 by Radiant Insights
Global Markets Direct's, 'Acute Pain - Pipeline Review, H1 2016', provides an overview of the Acute Pain pipeline
The report provides comprehensive information on the therapeutics under development for Acute Pain, complete
with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for Acute Pain and features dormant and
discontinued projects.
Browse Complete Summary Click Here @
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes
ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
- The report provides a snapshot of the global therapeutic landscape of Acute Pain
- The report reviews pipeline therapeutics for Acute Pain by companies and universities/research institutes based
on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description,
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Acute Pain therapeutics and enlists all their major and minor projects
- The report assesses Acute Pain therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Acute Pain
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Acute Pain
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Acute Pain pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Request Sample Copy of This Report @
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Acute Pain Overview 10
Therapeutics Development 11
Pipeline Products for Acute Pain - Overview 11
Pipeline Products for Acute Pain - Comparative Analysis 12
Acute Pain - Therapeutics under Development by Companies 13
Acute Pain - Therapeutics under Investigation by Universities/Institutes 17
Acute Pain - Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Acute Pain - Products under Development by Companies 22
Acute Pain - Products under Investigation by Universities/Institutes 26
Acute Pain - Companies Involved in Therapeutics Development 27
A. Menarini Industrie Farmaceutiche Riunite Srl 27
AcelRx Pharmaceuticals, Inc. 28
Adynxx, Inc. 29
Amorsa Therapeutics Inc. 30
Browse Complete Summary Click Here @
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure market research reports, helping them
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries
and a host of micro markets. In addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: [email protected]
Visit our Blog:
shweta187   документов Email
Пожаловаться на содержимое документа